产品简要
公司名称 :
HUABIO
产品类型 :
抗体
产品名称 :
SLC27A4重组兔单克隆抗体[JE58-29](HA720001)
目录 :
HA720001
规格 :
单克隆
价格 :
JE58-29
克隆性 :
单克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
克隆名称 :
JE58-29
反应物种 :
人类, 小鼠, 大鼠
应用 :
免疫印迹, 流式细胞仪, 免疫组化-石蜡切片
更多信息或购买 :
产品信息
Catalog# :
HA720001
产品名称 :
SLC27A4重组兔单克隆抗体[JE58-29](HA720001)
类别 :
Recombinant Rabbit monoclonal primary
共轭 :
未共轭
克隆性 :
单克隆
克隆编号 :
JE58-29
宿主 :
应用 :
免疫印迹, 免疫组化-P, FC
应用w/稀释 :
WB: 1:500-1:1, 000;免疫组化-P:1:50-1:200;FC:1:50-1:100
反应物种 :
人类, 小鼠, 大鼠
免疫原 :
Recombinant protein within human SLC27A4 aa 393-643.
抗体亚型 :
IgG
靶蛋白 :
SLC27A4
靶标.UniProt数据库 :
Q6P1M0
靶标.同义词 :
ACSVL 4 antibody; ACSVL4 antibody; EC 6.2.1 antibody; FATP 4 antibody; FATP4 antibody; Fatty acid transport protein 4 antibody; Fatty acid transport protein4 antibody; IPS antibody; Long chain fatty acid transport protein 4 antibody; Long chain fatty acid transport protein4 antibody; OTTHUMP00000022264 antibody; S27A4 antibody; SLC27 A4 antibody; SLC27A 4 antibody; Solute carrier family 27 (fatty acid transporter) member 4 antibody; Solute carrier family 27 member 4 antibody; Solute carrier family 27 member4 antibody
Target function/background :
This gene encodes a member of a family of fatty acid transport proteins, which are involved in translocation of long-chain fatty acids cross the plasma membrane. This protein is expressed at high levels on the apical side of mature enterocytes in the small intestine, and appears to be the principal fatty acid transporter in enterocytes. Clinical studies suggest this gene as a candidate gene for the insulin resistance syndrome. Mutations in this gene have been associated with ichthyosis prematurity syndrome.
产品形式 :
液体
纯化 :
蛋白质A亲和纯化
浓度 :
1微克/微升
储存缓冲液 :
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
储存空调 :
Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
分子量 :
72 kDa
供应商 :
HUABIO
Volume :
100ul
价格 :
355
launch date :
2020&prior
更多信息或购买 :
公司信息
HUABIO
Boston, Massachusetts
support@huabio.com
https://www.huabio.com
1-857-353-6600
公司总部: 美国
Founded in 2007, HUABIO is dedicated to developing high-quality antibodies that advance innovation. We are passionate about the accuracy, efficiency, and consistency of our products. That is why we have invested in new production platforms, like recombinant rabbit monoclonals, alpaca nanobodies, and adopted aggressive QA standards to deliver cutting-edge antibodies with uncompromised quality.
We hope to see you at your next discovery!